BDBM577483 US11472838, Compound 5

SMILES COC(=O)\C=C\CC[C@H](NC(=O)c1ccncc1C(O)=O)C(=O)N[C@H](C(=O)N1CC(=O)C[C@H]1C(=O)N[C@@H](C1CCCCC1)C(=O)N[C@@H](C1CCCCC1)C(N)=O)C(C)(C)C

InChI Key InChIKey=NPPFXOSTKHCNFF-UHFFFAOYSA-N

Data  24 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 24 hits for monomerid = 577483   

TargetCoagulation factor XIII B chain(Rabbit)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 7nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 67nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 2.13E+4nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 17nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 6.65E+4nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 445nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 1.10E+4nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 24nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Crab-eating macaque)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 19nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Pig)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 16nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Dog)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 24nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A/B chain(Human)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 10nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Rat)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 17nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Mouse)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 15nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 24nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A/B chain(Human)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 4nMAssay Description:The most relevant off-targets are the transglutaminase isoenzymes especially tissue transglutaminase (TG2) because the enzyme is ubiquitously express...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Crab-eating macaque)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 15nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Pig)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 365nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Dog)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 28nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII B chain(Rabbit)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 20nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Rat)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 8nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Mouse)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 19nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent

TargetCoagulation factor XIII A chain(Human)
Zedira

US Patent
LigandPNGBDBM577483(US11472838, Compound 5)
Affinity DataIC50: 16nMAssay Description:FXIIIa activity has been determined using substrate A101 (Zedira GmbH, Darmstadt, Germany), which is based on the N-terminal dodecapeptide of α2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/24/2022
Entry Details
Go to US Patent